Your browser doesn't support javascript.
loading
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.
Bhatnagar, Sumit; Mukherjee, Dwaipayan; Salem, Ahmed Hamed; Miles, Dale; Menon, Rajeev M; Gibbs, John P.
Affiliation
  • Bhatnagar S; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA. sumit.bhatnagar@abbvie.com.
  • Mukherjee D; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA.
  • Salem AH; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA.
  • Miles D; Clinical Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.
  • Menon RM; Clinical Pharmacology, Genentech Inc, South San Francisco, CA, USA.
  • Gibbs JP; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., 1 North Waukegan Road, Dept. R4PK, Bldg. AP31-3, North Chicago, IL, 60064, USA.
Cancer Chemother Pharmacol ; 87(4): 465-474, 2021 04.
Article in En | MEDLINE | ID: mdl-33398386

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Triazoles / Bridged Bicyclo Compounds, Heterocyclic Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Main subject: Sulfonamides / Triazoles / Bridged Bicyclo Compounds, Heterocyclic Type of study: Guideline / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Type: Article Affiliation country: United States